WO2006124716A2 - Fully automated control system for type 1 diabetes - Google Patents

Fully automated control system for type 1 diabetes

Info

Publication number
WO2006124716A2
WO2006124716A2 PCT/US2006/018620 US2006018620W WO2006124716A2 WO 2006124716 A2 WO2006124716 A2 WO 2006124716A2 US 2006018620 W US2006018620 W US 2006018620W WO 2006124716 A2 WO2006124716 A2 WO 2006124716A2
Authority
WO
WIPO (PCT)
Prior art keywords
insulin
subject
counter
regulatory
glucose level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/018620
Other languages
English (en)
French (fr)
Other versions
WO2006124716A3 (en
Inventor
Edward Damiano
Firas El-Khatib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Priority to CA2612714A priority Critical patent/CA2612714C/en
Priority to JP2008511449A priority patent/JP5037496B2/ja
Priority to EP06752536.0A priority patent/EP1881786B1/en
Priority to US11/914,146 priority patent/US7806854B2/en
Publication of WO2006124716A2 publication Critical patent/WO2006124716A2/en
Publication of WO2006124716A3 publication Critical patent/WO2006124716A3/en
Anticipated expiration legal-status Critical
Priority to US12/847,153 priority patent/US8273052B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • the steady-state blood-glucose value, y , ⁇ can be approximated from the pharmacodynamics of insulin, which is available in the literature. Augmenting the scaled y k -system of (20) to the original y k -system of (1), we obtain the singkv-input multiple-output model given by (21) wh is a vector of two white-noise sequences, and
  • step 32 the insulin and glucagon dose control signals u(t) are generated based on (a) a difference between the predicted glucose level signal y(t+k
  • the present invention may be embodied as an overall system such as shown in Figure 1, as an overall method, as a controller such as shown in Figure 2, and as a method performed by a controller such as shown in Figure 4.
  • the method may be performed by computer program instructions executed by generic controller hardware including memory, a processing or execution unit, and input/output circuitry.
  • the instructions may be provided to the controller from a computer-readable medium such as semiconductor memory, magnetic memory (e.g. magnetic disk), optical memory (e.g. optical disk such as CD, DVD), etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PCT/US2006/018620 2005-05-13 2006-05-15 Fully automated control system for type 1 diabetes Ceased WO2006124716A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2612714A CA2612714C (en) 2005-05-13 2006-05-15 Fully automated control system for type 1 diabetes
JP2008511449A JP5037496B2 (ja) 2005-05-13 2006-05-15 １型糖尿病用の完全自動制御システム
EP06752536.0A EP1881786B1 (en) 2005-05-13 2006-05-15 Fully automated control system for type 1 diabetes
US11/914,146 US7806854B2 (en) 2005-05-13 2006-05-15 Fully automated control system for type 1 diabetes
US12/847,153 US8273052B2 (en) 2005-05-13 2010-07-30 Fully automated control system for type 1 diabetes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68112805P 2005-05-13 2005-05-13
US60/681,128 2005-05-13
US73556805P 2005-11-10 2005-11-10
US60/735,568 2005-11-10

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/914,146 A-371-Of-International US7806854B2 (en) 2005-05-13 2006-05-15 Fully automated control system for type 1 diabetes
US12/847,153 Continuation US8273052B2 (en) 2005-05-13 2010-07-30 Fully automated control system for type 1 diabetes

Publications (2)

Publication Number Publication Date
WO2006124716A2 true WO2006124716A2 (en) 2006-11-23
WO2006124716A3 WO2006124716A3 (en) 2007-03-08

Family

ID=37431958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/018620 Ceased WO2006124716A2 (en) 2005-05-13 2006-05-15 Fully automated control system for type 1 diabetes

Country Status (5)

Country Link
US (2) US7806854B2 (enExample)
EP (1) EP1881786B1 (enExample)
JP (2) JP5037496B2 (enExample)
CA (1) CA2612714C (enExample)
WO (1) WO2006124716A2 (enExample)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099356A3 (en) * 2007-02-15 2008-10-16 Koninkl Philips Electronics Nv Drug delivery device
WO2008157780A1 (en) * 2007-06-21 2008-12-24 University Of Virginia Patent Foundation Lqg artificial pancreas control system and related method
EP2093685A1 (en) * 2008-02-21 2009-08-26 F.Hoffmann-La Roche Ag Drug administration device having a bolus administration profile controller
WO2009115948A1 (en) * 2008-03-17 2009-09-24 Philips Intellectual Property & Standards Gmbh A closed loop system for automatically controlling a physiological variable of a patient
WO2010094904A1 (fr) 2009-02-23 2010-08-26 Supelec Système de régulation du glucose sanguin d'un sujet vivant diabétique et produit programme d'ordinateur correspondant
US20110208156A1 (en) * 2010-02-11 2011-08-25 The Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US20110282321A1 (en) * 2007-01-31 2011-11-17 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US9833570B2 (en) 2010-10-31 2017-12-05 Trustees Of Boston University Blood glucose control system
US9833191B2 (en) 2012-11-07 2017-12-05 Bigfoot Biomedical, Inc. Computer-based diabetes management
US10188793B2 (en) 2014-06-10 2019-01-29 Bigfoot Biomedical, Inc. Insulin on board calculation, schedule and delivery
WO2019090016A1 (en) * 2017-11-02 2019-05-09 Boston Scientific Scimed, Inc. Systems and methods for graded glucose control
US10307538B2 (en) 2016-01-14 2019-06-04 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10610644B2 (en) 2017-01-13 2020-04-07 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
DE102018009902A1 (de) * 2018-12-20 2020-06-25 B. Braun Melsungen Ag Verfahren und Vorrichtung zur Erstellung eines kontinuierlichen Verlaufs und zur Vorhersage der Fluidbilanz eines Patienten
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881792B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10940267B2 (en) 2019-07-16 2021-03-09 Beta Bionics, Inc. Blood glucose control system with real-time glycemic control optimization
US11027063B2 (en) 2017-01-13 2021-06-08 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US11154656B2 (en) 2019-07-16 2021-10-26 Beta Bionics, Inc. Blood glucose control system with medicament bolus recommendation
US11304633B2 (en) 2017-11-02 2022-04-19 Boston Scientific Scimed, Inc. System and method for providing glucose control therapy
WO2022204705A1 (en) * 2021-03-25 2022-09-29 Beta Bionics, Inc. Emergency medicament dose control
JP2023516717A (ja) * 2020-03-04 2023-04-20 イーオーフロウ カンパニー リミテッド 薬液制御注入デバイス
US20230166035A1 (en) * 2021-03-25 2023-06-01 Beta Bionics, Inc. Emergency medicament dose control
US11744945B2 (en) 2015-08-07 2023-09-05 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
USRE50075E1 (en) 2014-01-31 2024-08-13 Trustees Of Boston University Glucose level control system with offline control based on preceding periods of online control
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points

Families Citing this family (218)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7314859B2 (en) 2002-12-27 2008-01-01 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
EP1578262A4 (en) 2002-12-31 2007-12-05 Therasense Inc CONTINUOUS BLOOD SUGAR MONITORING SYSTEM AND USE METHOD
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
CA2556331A1 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
CA3090413C (en) 2004-06-04 2023-10-10 Abbott Diabetes Care Inc. Glucose monitoring and graphical representations in a data management system
US7814838B2 (en) * 2004-06-28 2010-10-19 Automotive Systems, Laboratory, Inc. Gas generating system
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US8956291B2 (en) * 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7806854B2 (en) * 2005-05-13 2010-10-05 Trustees Of Boston University Fully automated control system for type 1 diabetes
CN102440785A (zh) 2005-08-31 2012-05-09 弗吉尼亚大学专利基金委员会 传感器信号处理方法及传感器信号处理装置
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8583205B2 (en) 2008-03-28 2013-11-12 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US20110054391A1 (en) * 2006-07-28 2011-03-03 Ward W Kenneth Analyte sensing and response system
US8135548B2 (en) 2006-10-26 2012-03-13 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US20080199894A1 (en) 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
CA2683959C (en) 2007-04-14 2017-08-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
CA2683930A1 (en) 2007-04-14 2008-10-23 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
CA2683863C (en) 2007-04-14 2019-01-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US7768387B2 (en) 2007-04-14 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
CA2683962C (en) 2007-04-14 2017-06-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7751907B2 (en) 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
US8221345B2 (en) 2007-05-30 2012-07-17 Smiths Medical Asd, Inc. Insulin pump based expert system
JP2010531169A (ja) 2007-06-21 2010-09-24 アボット ダイアベティス ケア インコーポレイテッド 健康監視装置
WO2008157820A1 (en) 2007-06-21 2008-12-24 Abbott Diabetes Care, Inc. Health management devices and methods
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US7768386B2 (en) 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
EP2695573B1 (en) 2007-10-10 2021-04-28 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
WO2010011805A1 (en) * 2008-07-24 2010-01-28 Admetsys Corporation Device and method for automatically sampling and measuring blood analytes
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US20100057040A1 (en) 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
EP2393413B1 (en) 2009-02-04 2015-10-14 Sanofi-Aventis Deutschland GmbH Medical device and method for glycemic control
US10478100B2 (en) 2009-02-04 2019-11-19 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing information for glycemic control
US8062249B2 (en) * 2009-03-31 2011-11-22 Abbott Diabetes Care Inc. Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model
WO2010121084A1 (en) 2009-04-15 2010-10-21 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010127051A1 (en) 2009-04-29 2010-11-04 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
WO2010127187A1 (en) 2009-04-29 2010-11-04 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
EP2432377A1 (en) 2009-05-22 2012-03-28 Abbott Diabetes Care, Inc. Usability features for integrated insulin delivery system
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
WO2011014851A1 (en) 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
WO2011026148A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
DK3988470T3 (da) 2009-08-31 2023-08-28 Abbott Diabetes Care Inc Visningsindretninger til en medicinsk indretning
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc ANALYTICAL SIGNAL PROCESSING APPARATUS AND METHOD
EP3001194B1 (en) 2009-08-31 2019-04-17 Abbott Diabetes Care, Inc. Medical devices and methods
DK2482870T3 (en) 2009-09-29 2018-04-16 Admetsys Corp Plant and method for distinguishing containers in the delivery of medicines
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
AU2010302266A1 (en) 2009-09-30 2012-04-19 Dreamed Diabetes Ltd. Monitoring Device for Management of Insulin Delivery
US8185181B2 (en) 2009-10-30 2012-05-22 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US8882701B2 (en) 2009-12-04 2014-11-11 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
WO2011112753A1 (en) 2010-03-10 2011-09-15 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US8945094B2 (en) * 2010-09-08 2015-02-03 Honeywell International Inc. Apparatus and method for medication delivery using single input-single output (SISO) model predictive control
EP2624745A4 (en) 2010-10-07 2018-05-23 Abbott Diabetes Care, Inc. Analyte monitoring devices and methods
CA2816388C (en) * 2010-10-12 2016-12-06 The Regents Of The University Of California Maintaining multiple defined physiological zones using model predictive control
AU2012254094B2 (en) 2011-02-28 2016-08-25 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
EP4324399A3 (en) 2011-04-15 2024-05-15 DexCom, Inc. Advanced analyte sensor calibration and error detection
EP3556285B1 (en) 2011-06-16 2022-08-31 Abbott Diabetes Care, Inc. Temperature-compensated analyte monitoring devices, systems, and methods thereof
WO2013066849A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
JP6443802B2 (ja) 2011-11-07 2018-12-26 アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． 分析物モニタリング装置および方法
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
WO2013078426A2 (en) 2011-11-25 2013-05-30 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
LT4056105T (lt) 2011-12-11 2024-01-10 Abbott Diabetes Care, Inc. Analitės jutiklių įrenginiai
WO2013113391A2 (en) * 2012-02-02 2013-08-08 Brainlab Ag Method for determining an infusion parameter
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9757510B2 (en) 2012-06-29 2017-09-12 Animas Corporation Method and system to handle manual boluses or meal events for closed-loop controllers
WO2014035732A1 (en) 2012-08-30 2014-03-06 Abbot Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
EP2901153A4 (en) 2012-09-26 2016-04-27 Abbott Diabetes Care Inc METHOD AND DEVICE FOR IMPROVING DELAY CORRECTION FUNCTION DURING IN VIVO MEASUREMENT OF ANALYZ CONCENTRATION WITH ANALYZ CONCENTRATION VARIABILITY AND RANGE DATA
US9907909B2 (en) 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
WO2014110541A1 (en) * 2013-01-14 2014-07-17 The Regents Of University Of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
US9940441B2 (en) 2013-03-13 2018-04-10 Tandem Diabetes Care, Inc. System and method for maximum insulin pump bolus override
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US20160038673A1 (en) * 2013-03-15 2016-02-11 Animas Corporation Insulin time-action model
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
EP3041528A4 (en) 2013-09-06 2017-04-26 Tandem Diabetes Care, Inc. System and method for mitigating risk in automated medicament dosing
WO2015061691A1 (en) 2013-10-24 2015-04-30 Trustees Of Boston University Infusion system employing a multi-channel lumen assembly for preventing mischanneling of multiple medicaments
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
US9750878B2 (en) * 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Closed-loop control of glucose according to a predicted blood glucose trajectory
US9750877B2 (en) * 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Predicted time to assess and/or control a glycemic state
EP3089666B1 (en) 2013-12-31 2020-08-19 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
EP4151150B1 (en) 2014-03-30 2025-08-27 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
CA2953385C (en) 2014-06-30 2024-07-02 Evolving Machine Intelligence Pty Ltd SYSTEM AND METHOD FOR MODELING SYSTEM BEHAVIOR
CN104181958B (zh) * 2014-07-22 2016-06-08 南京归图科技发展有限公司 一种过热汽温快速节能预测控制方法
US9983554B2 (en) 2014-11-25 2018-05-29 Mitsubishi Electric Research Laboratories, Inc. Model predictive control with uncertainties
CN107405446B (zh) 2015-02-18 2020-09-29 英赛罗公司 流体输送和输注装置及其使用方法
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10064994B2 (en) 2015-05-22 2018-09-04 Iowa State University Research Foundation, Inc. Automatic insulin delivery system
US10281897B2 (en) 2015-06-02 2019-05-07 Mitsubishi Electric Research Laboratories, Inc. Model predictive control with uncertainties
CN108024765B (zh) 2015-07-10 2021-06-11 雅培糖尿病护理公司 对于生理参数进行动态葡萄糖曲线响应的系统、装置和方法
EP3374900B1 (en) 2016-01-05 2025-06-11 Insulet Corporation Operating multi-modal medicine delivery systems
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
AU2017206786B2 (en) * 2016-01-12 2022-01-27 President And Fellows Of Harvard College Predictive control model for the artificial pancreas using past predictions
HK1257246A1 (zh) 2016-01-13 2019-10-18 Bigfoot Biomedical, Inc. 糖尿病管理系统的用户界面
US10610643B2 (en) 2016-01-14 2020-04-07 Bigfoot Biomedical, Inc. Occlusion resolution in medication delivery devices, systems, and methods
US11167081B2 (en) 2016-06-16 2021-11-09 Smiths Medical Asd, Inc. Assemblies and methods for infusion pump system administration sets
WO2018009614A1 (en) 2016-07-06 2018-01-11 President And Fellows Of Harvard College Event-triggered model predictive control for embedded artificial pancreas systems
US10765807B2 (en) 2016-09-23 2020-09-08 Insulet Corporation Fluid delivery device with sensor
US10792421B2 (en) 2016-10-05 2020-10-06 Iowa State University Research Foundation, Inc. Automatic insulin delivery system with minimized input variable lag
CA3037432A1 (en) 2016-12-12 2018-06-21 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
EP3570735A4 (en) 2017-01-23 2020-10-21 Abbott Diabetes Care Inc. SYSTEMS, DEVICES AND METHODS FOR INSERTING ANALYTE SENSOR
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11497851B2 (en) 2017-03-31 2022-11-15 Lifescan Ip Holdings, Llc Maintaining maximum dosing limits for closed loop insulin management systems
EP3970611B1 (en) * 2017-05-05 2023-12-06 Ypsomed AG Closed loop control of physiological glucose
US12161463B2 (en) 2017-06-09 2024-12-10 President And Fellows Of Harvard College Prevention of post-bariatric hypoglycemia using a novel glucose prediction algorithm and mini-dose stable glucagon
EP3655065A4 (en) 2017-07-19 2021-08-18 Smiths Medical ASD, Inc. BOX ARRANGEMENTS FOR INFUSION PUMPS
EP3438858A1 (en) 2017-08-02 2019-02-06 Diabeloop Closed-loop blood glucose control systems and methods
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
DK3700416T3 (da) 2017-10-24 2024-09-30 Dexcom Inc På forhånd forbundne analytsensorer
AU2018388898A1 (en) 2017-12-21 2020-06-11 Ypsomed Ag Closed loop control of physiological glucose
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US12128212B2 (en) 2018-06-19 2024-10-29 President And Fellows Of Harvard College Adaptive zone model predictive control with a glucose and velocity dependent dynamic cost function for an artificial pancreas
AU2019288473A1 (en) 2018-06-22 2020-12-10 Ypsomed Ag Insulin and pramlintide delivery systems, methods, and devices
US11147922B2 (en) 2018-07-13 2021-10-19 Iowa State University Research Foundation, Inc. Feedback predictive control approach for processes with time delay in the manipulated variable
CA3106452A1 (en) * 2018-09-24 2020-04-02 Amgen Inc. Interventional dosing systems and methods
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
WO2020077223A1 (en) 2018-10-11 2020-04-16 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11464908B2 (en) 2019-02-18 2022-10-11 Tandem Diabetes Care, Inc. Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps
US20220189632A1 (en) * 2019-03-15 2022-06-16 3M Innovative Properties Company Individualized medicine using causal models
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4042441A4 (en) 2019-10-04 2023-10-11 Beta Bionics, Inc. GLUCOSE REGULATION SYSTEM
WO2021113647A1 (en) 2019-12-06 2021-06-10 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US12036389B2 (en) 2020-01-06 2024-07-16 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
WO2022140204A1 (en) 2020-12-21 2022-06-30 Beta Bionics, Inc. Medicament pumps and control systems thereof
EP4100958A1 (en) 2020-02-03 2022-12-14 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
USD1032624S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
WO2021183611A1 (en) * 2020-03-10 2021-09-16 Trustees Of Boston University Integrated user-defined input into a closed-loop glucose control system
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
USD1032623S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11911595B2 (en) 2020-05-18 2024-02-27 Tandem Diabetes Care, Inc. Systems and methods for automated insulin delivery response to meal announcements
EP4185348A1 (en) 2020-07-22 2023-05-31 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US11951284B2 (en) 2020-08-27 2024-04-09 Tandem Diabetes Care, Inc. Transitioning to other modes in automated insulin delivery
AU2021333904A1 (en) 2020-08-31 2023-03-02 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte sensor insertion
WO2022072332A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
EP4221588A1 (en) 2020-09-30 2023-08-09 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US20220189603A1 (en) 2020-12-07 2022-06-16 Beta Bionics, Inc. Medicament pumps and control systems for managing glucose control therapy data of a subject
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US20220265143A1 (en) 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
WO2022192482A1 (en) 2021-03-10 2022-09-15 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (en) 2021-06-07 2022-12-14 Insulet Corporation Exercise safety prediction based on physiological conditions
WO2023049900A1 (en) 2021-09-27 2023-03-30 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
CA3275991A1 (en) 2023-01-06 2024-07-11 Insulet Corporation Automatic or manual administration of meal boluses with subsequent automatic relaxation of safety constraints

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030208113A1 (en) 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280494A (en) 1979-06-26 1981-07-28 Cosgrove Robert J Jun System for automatic feedback-controlled administration of drugs
GB8615662D0 (en) 1986-06-26 1986-07-30 Exxon Chemical Patents Inc Polymers
EP0374140A4 (en) * 1987-08-28 1990-06-27 Univ Minnesota METABOLIC SENSOR FOR DRUG ADMINISTRATION.
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6669663B1 (en) * 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
JP2003521972A (ja) * 1999-09-24 2003-07-22 ヘルセテック インコーポレイテッド 生理学的監視装置およびこれと関連する計算・表示・通信装置
US6925393B1 (en) * 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
DE10006044A1 (de) * 2000-02-10 2001-08-16 Roche Diagnostics Gmbh Anordnung und Verfahren zur Dosierung eines die Blutglukose eines Patienten regulierenden Hormons
AU2001292946A1 (en) 2000-09-26 2002-04-08 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US20030073609A1 (en) 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
GB0206792D0 (en) * 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
US20040010207A1 (en) * 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US9872890B2 (en) * 2003-03-19 2018-01-23 Paul C. Davidson Determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US7806854B2 (en) * 2005-05-13 2010-10-05 Trustees Of Boston University Fully automated control system for type 1 diabetes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030208113A1 (en) 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1881786A4

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110282321A1 (en) * 2007-01-31 2011-11-17 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US10154804B2 (en) 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US10856786B2 (en) 2007-01-31 2020-12-08 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US11918349B2 (en) 2007-01-31 2024-03-05 Medtronic Minimed, Inc. Model predictive control for diabetes management
WO2008099356A3 (en) * 2007-02-15 2008-10-16 Koninkl Philips Electronics Nv Drug delivery device
WO2008157780A1 (en) * 2007-06-21 2008-12-24 University Of Virginia Patent Foundation Lqg artificial pancreas control system and related method
US11058818B2 (en) 2007-06-21 2021-07-13 University Of Virginia Patent Foundation LQG artificial pancreas control system and related method
US10173006B2 (en) 2007-06-21 2019-01-08 University Of Virginia Patent Foundation LQG artificial pancreas control system and related method
US8715268B2 (en) 2008-02-21 2014-05-06 Roche Diagnostics International Ag Administration device having a bolus administration profile controller
WO2009103492A1 (en) * 2008-02-21 2009-08-27 Roche Diagnostics Gmbh Drug administration device having a bolus administration profile controller
EP2093685A1 (en) * 2008-02-21 2009-08-26 F.Hoffmann-La Roche Ag Drug administration device having a bolus administration profile controller
WO2009115948A1 (en) * 2008-03-17 2009-09-24 Philips Intellectual Property & Standards Gmbh A closed loop system for automatically controlling a physiological variable of a patient
FR2942387A1 (fr) * 2009-02-23 2010-08-27 Ecole Superieure Electricite Systeme de regulation du glucose sanguin d'un sujet vivant diabetique et produit programme d'ordinateur correspondant.
WO2010094904A1 (fr) 2009-02-23 2010-08-26 Supelec Système de régulation du glucose sanguin d'un sujet vivant diabétique et produit programme d'ordinateur correspondant
US8762070B2 (en) * 2010-02-11 2014-06-24 Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US20110208156A1 (en) * 2010-02-11 2011-08-25 The Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US10188795B2 (en) 2010-10-31 2019-01-29 Trustees Of Boston University Blood glucose control system
US9833570B2 (en) 2010-10-31 2017-12-05 Trustees Of Boston University Blood glucose control system
USRE50080E1 (en) 2010-10-31 2024-08-20 Trustees Of Boston University Blood glucose control system
US9833191B2 (en) 2012-11-07 2017-12-05 Bigfoot Biomedical, Inc. Computer-based diabetes management
USRE50075E1 (en) 2014-01-31 2024-08-13 Trustees Of Boston University Glucose level control system with offline control based on preceding periods of online control
US10188793B2 (en) 2014-06-10 2019-01-29 Bigfoot Biomedical, Inc. Insulin on board calculation, schedule and delivery
US11376362B2 (en) 2014-06-10 2022-07-05 Bigfoot Biomedical, Inc. Systems for determining insulin on board and recommending insulin therapy and related methods
US12280241B2 (en) 2015-08-07 2025-04-22 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
US11744945B2 (en) 2015-08-07 2023-09-05 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
US12303668B2 (en) 2016-01-14 2025-05-20 Insulet Corporation Adjusting insulin delivery rates
US10780223B2 (en) 2016-01-14 2020-09-22 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US10835671B2 (en) 2016-01-14 2020-11-17 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US10307538B2 (en) 2016-01-14 2019-06-04 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US11857763B2 (en) 2016-01-14 2024-01-02 Insulet Corporation Adjusting insulin delivery rates
US11147921B2 (en) 2016-01-14 2021-10-19 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
US11033682B2 (en) 2017-01-13 2021-06-15 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US12485223B2 (en) 2017-01-13 2025-12-02 Insulet Corporation Controlling insulin delivery
US12343502B2 (en) 2017-01-13 2025-07-01 Insulet Corporation System and method for adjusting insulin delivery
US12318577B2 (en) 2017-01-13 2025-06-03 Insulet Corporation System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11446439B2 (en) 2017-01-13 2022-09-20 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US12161841B2 (en) 2017-01-13 2024-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US11511039B2 (en) 2017-01-13 2022-11-29 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US11565045B2 (en) 2017-01-13 2023-01-31 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10610644B2 (en) 2017-01-13 2020-04-07 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US12042630B2 (en) 2017-01-13 2024-07-23 Insulet Corporation System and method for adjusting insulin delivery
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11969579B2 (en) 2017-01-13 2024-04-30 Insulet Corporation Insulin delivery methods, systems and devices
US11027063B2 (en) 2017-01-13 2021-06-08 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10881792B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11304633B2 (en) 2017-11-02 2022-04-19 Boston Scientific Scimed, Inc. System and method for providing glucose control therapy
WO2019090016A1 (en) * 2017-11-02 2019-05-09 Boston Scientific Scimed, Inc. Systems and methods for graded glucose control
DE102018009902A1 (de) * 2018-12-20 2020-06-25 B. Braun Melsungen Ag Verfahren und Vorrichtung zur Erstellung eines kontinuierlichen Verlaufs und zur Vorhersage der Fluidbilanz eines Patienten
US12204889B2 (en) 2019-07-16 2025-01-21 Beta Bionics, Inc. Ambulatory medicament device alarm system
US11766518B2 (en) 2019-07-16 2023-09-26 Beta Bionics, Inc. Glucose level control system with control parameter modification
US11744947B2 (en) 2019-07-16 2023-09-05 Beta Bionics, Inc. Glucose control system with control parameter modification
US12093681B2 (en) 2019-07-16 2024-09-17 Beta Bionics, Inc. Ambulatory medicament device with security override passcode
US11116902B2 (en) 2019-07-16 2021-09-14 Beta Bionics, Inc. Blood glucose control system with control parameter modification
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
US10940267B2 (en) 2019-07-16 2021-03-09 Beta Bionics, Inc. Blood glucose control system with real-time glycemic control optimization
US11941392B2 (en) 2019-07-16 2024-03-26 Beta Bionics, Inc. Ambulatory medical device with malfunction alert prioritization
US11154656B2 (en) 2019-07-16 2021-10-26 Beta Bionics, Inc. Blood glucose control system with medicament bolus recommendation
US10960137B2 (en) 2019-07-16 2021-03-30 Beta Bionics, Inc. Blood glucose control system with automated backup therapy protocol generation
JP2023516717A (ja) * 2020-03-04 2023-04-20 イーオーフロウ カンパニー リミテッド 薬液制御注入デバイス
US20230166035A1 (en) * 2021-03-25 2023-06-01 Beta Bionics, Inc. Emergency medicament dose control
US12465686B2 (en) * 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
WO2022204705A1 (en) * 2021-03-25 2022-09-29 Beta Bionics, Inc. Emergency medicament dose control

Also Published As

Publication number Publication date
US8273052B2 (en) 2012-09-25
JP2008545454A (ja) 2008-12-18
US20080208113A1 (en) 2008-08-28
JP5037496B2 (ja) 2012-09-26
US7806854B2 (en) 2010-10-05
JP2012086032A (ja) 2012-05-10
EP1881786B1 (en) 2017-11-15
CA2612714C (en) 2013-09-24
CA2612714A1 (en) 2006-11-23
WO2006124716A3 (en) 2007-03-08
US20110106049A1 (en) 2011-05-05
JP5389147B2 (ja) 2014-01-15
EP1881786A4 (en) 2009-05-27
EP1881786A2 (en) 2008-01-30

Similar Documents

Publication Publication Date Title
US7806854B2 (en) Fully automated control system for type 1 diabetes
US12380981B2 (en) Closed loop control of physiological glucose
EP2166946B1 (en) Lqg artificial pancreas control system and related method
CA2816314C (en) Blood glucose control system
US20160331898A1 (en) Glucose level control system with offline control based on preceding periods of online control
JP7290624B2 (ja) 閉ループ血糖制御システム及び閉ループ血糖制御システムの作動方法
JP7042807B2 (ja) 患者の血糖値を制御するための自動システム
JP7042808B2 (ja) 患者の血糖値を制御するための自動システム
Jafar et al. Long-term use of the hybrid artificial pancreas by adjusting carbohydrate ratios and programmed basal rate: A reinforcement learning approach
US20220246265A1 (en) Systems and Methods for Risk Based Insulin Delivery Conversion
EP3438986B1 (en) Closed-loop blood glucose control systems and methods
JP7424996B2 (ja) 患者の血糖値をモニタするための自動システム
EP2836943B1 (en) Method for providing a value of insulin and the related system
EP4338667A1 (en) Method for estimating an unannounced meal ingested
EP4651145A1 (en) Closed-loop blood glucose control systems and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2008511449

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2612714

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 11914146

Country of ref document: US

REEP Request for entry into the european phase

Ref document number: 2006752536

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006752536

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU